Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by Dana-Farber Cancer Institute
Sponsor:
Collaborator:
Translational Breast Cancer Research Consortium
Information provided by (Responsible Party):
Rachel Freedman, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01494662
First received: December 14, 2011
Last updated: December 16, 2016
Last verified: December 2016